ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686557 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686557; 2) Community: the network communities that were significantly associated with the response to NSC 686557; 3) Molecule: the relationships between components within communities and NSC 686557; 4) MDR: the compounds that were significantly associated with the NSC 686557.

NSC Compound Enrichment Correlation
NSC 715407 Null 0.0401206532535671 0.24771053
NSC 718564 Null 0.0401206532535671 0.050048744
NSC 718781 Erlotinib hydrochloride 0.0401206532535671 -0.089696457
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0401206532535671 0.35068612
NSC 720134 Null 0.0401206532535671 0.0059855883
NSC 720495 Null 0.0401206532535671 0.1494603
NSC 726217 Combretastatin A4-analogue 0.0401206532535671 0.13624359
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0401206532535671 0.10272183
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0401206532535671 0.26455494
NSC 734287 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0401206532535671 0.081627217
Total:124  Current:109    [First] [Prev] [Next] [Last]